Anastomosis Devices Market Size & Forecast Report, 2014 - 2025

The global anastomosis devices market was valued at 15.74 Million in 2016 and is expected to continue growing at a higher rate. Factors such as a rise in surgical procedures with rising incidences of cardiovascular and GT diseases are likely to contribute to the market growth in the forecast period. Overall, the anastomosis devices market is expected to cross a CAGR of 5.2% in the forecast period.

Surgical procedures have now turned into a perplexing form for cardiac surgeons right from the inception of coronary arteries bypass grafts and minimally invasive techniques. Suture technique for coronary anastomosis is becoming insufficient to suffice new demands from surgeons hence a need arises for alternative techniques to perform coronary bypasses. Due to the recent medical advancements, sutureless devices are based on memory shape metal alloy, synthetic, and biologic glue combined or non-combined with the metallic framework and laser bonding using organic soldering techniques.

Anastomosis devices are easy to use and reduce the dependency on surgeons, which is the analytical factor for long-term potency. The key element of sutures is placed between graft vessels and target and any distortion might result in obstruction of flow. Therefore, anastomotic devices are made available for minimally invasive or endoscopic use to reduce heart operations via limited incisions. For instance, the heartfelt anastomotic device is a micromechanical-suturing device for coronary artery bypass grafting. However, an ideal anastomotic method is considered only when compression anastomosis has no foreign bodies left at the anastomotic site.

The anastomosis devices industry is segmented based on product, application, and geography. Reusable and disposable categories form the bifurcation for the product categories in the market. The “Application” segment for the anastomosis devices market includes general surgeries, cardiovascular diseases, orthopedic surgeries, and ophthalmic surgeries.

Geographical segmentation for the anastomosis devices industry spans North America, Latin America, Europe, Asia-Pacific, the Middle East, and Africa. The north American anastomosis devices market is expected to rise at a higher CAGR in the forecast period due to rising medical assistance for cardiovascular diseases. Asia-Pacific’s anastomosis devices industry is likely to expand at a staggering CAGR in the forthcoming period due to the rise in the young workforce, change in lifestyle leading to the occurrence of chronic as well as acute ailments.

The key players in the anastomosis devices industry include Medtronic; LivaNova PLC; MAQUET Holding B.V. & Co. KG., Dextera Surgical Inc., Vitalitec International Inc., Synovis Micro Companies Alliance Inc., and Ethicon US, LLC.

Market Segment:

Anastomosis Devices Product Type Outlook (Revenue, USD Million, 2014 - 2025)
    • Disposable
    • Reusable

Anastomosis Devices Application Outlook (Revenue, USD Million, 2014 - 2025)
    • Cardiovascular Surgery
    • Gastrointestinal Surgery
    • Others

Anastomosis Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
        • U.S.
        • Canada
    • Europe
        • U.K.
        • Germany
    • the Asia Pacific
        • Japan
        • China
        • India
    • Latin America
        • Brazil
        • Mexico
    • MEA
        • South Africa